Physician profile
Bryan M Armitage
NPI 1952538316
$10,632.91
in general payments reported to CMS, 2019-2025
14 companies · $3,035 in 2025
The $3,035 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $153 · 2021: $137 · 2022: $67.96 · 2023: $61.17 · 2024: $6,238 · 2025: $3,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,308 · Food and Beverage: $3,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,307.94 |
| Food and Beverage | $3,025.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,606.94 | 2019-2025 | Pro, Mako, Aequalis Ascend Flex |
| Medical Device Business Services, INC. | $1,545.53 | 2024 | Na |
| Arthrex, INC. | $1,034.90 | 2025 | |
| Foundation Medical, LLC | $537.09 | 2025 | |
| Depuy Synthes Sales INC. | $180.30 | 2024 | Fibergraft Aeridyan Matrix, Na |
| Bone Support INC. | $132.03 | 2024 | Cerament G, Ceramentbone Void Filler |
| Smith+Nephew, INC. | $114.58 | 2020-2024 | Evos |
| Flower Orthopedics Coporation | $98.62 | 2025 | |
| Ossdsign USA Incorporated | $84.12 | 2025 | Ossdsign Catalyst |
| Urgo Medical North America, LLC | $74.76 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Biocomposites INC | $74.14 | 2019 | |
| Medtronic, INC. | $66.90 | 2021 | |
| Medtronic USA, INC. | $52.93 | 2019 | |
| Si-Bone, INC. | $30.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Armitage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.